Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP210560.RA_Qx6W3jZOCC0_xQAm__zYd0cujncy4QL6SeXBNj0DqU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP210560.RA_Qx6W3jZOCC0_xQAm__zYd0cujncy4QL6SeXBNj0DqU130_assertion type Assertion NP210560.RA_Qx6W3jZOCC0_xQAm__zYd0cujncy4QL6SeXBNj0DqU130_head.
- NP210560.RA_Qx6W3jZOCC0_xQAm__zYd0cujncy4QL6SeXBNj0DqU130_assertion description "[The MEF2A mutations may account for up to 1.93% of the disease population; thus, genetic testing based on mutational analysis of MEF2A may soon be available for many coronary artery disease/myocardial infarction patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP210560.RA_Qx6W3jZOCC0_xQAm__zYd0cujncy4QL6SeXBNj0DqU130_provenance.
- NP210560.RA_Qx6W3jZOCC0_xQAm__zYd0cujncy4QL6SeXBNj0DqU130_assertion evidence source_evidence_literature NP210560.RA_Qx6W3jZOCC0_xQAm__zYd0cujncy4QL6SeXBNj0DqU130_provenance.
- NP210560.RA_Qx6W3jZOCC0_xQAm__zYd0cujncy4QL6SeXBNj0DqU130_assertion SIO_000772 15861005 NP210560.RA_Qx6W3jZOCC0_xQAm__zYd0cujncy4QL6SeXBNj0DqU130_provenance.
- NP210560.RA_Qx6W3jZOCC0_xQAm__zYd0cujncy4QL6SeXBNj0DqU130_assertion wasDerivedFrom lhgdn-20090331 NP210560.RA_Qx6W3jZOCC0_xQAm__zYd0cujncy4QL6SeXBNj0DqU130_provenance.
- NP210560.RA_Qx6W3jZOCC0_xQAm__zYd0cujncy4QL6SeXBNj0DqU130_assertion wasGeneratedBy ECO_0000203 NP210560.RA_Qx6W3jZOCC0_xQAm__zYd0cujncy4QL6SeXBNj0DqU130_provenance.